Position in RGNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$887,083
+$789,406 QoQ
Shares Held
74,047
+535.3% QoQ
Ownership
0.112%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 164 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RGNX Over Time
Shares Held
Position Value (USD)
Derivatives in RGNX
reported options exposure · as of Sep 30, 2023CallValue
$2,370,240
CallShares
144,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. RGNX ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in RGNX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $887,083 | 74,047 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $97,677 | 11,656 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $150,120 | 10,425 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $6,544,191 | 797,100 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,999,253 | 1,398,497 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,176,298 | 1,187,102 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,749,943 | 1,120,109 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,438,565 | 806,715 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,995,941 | 426,955 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,519,510 | 196,073 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $12,964,274 | 787,623 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $2,370,240 | 144,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $10,973,430 | 548,946 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $1,059,470 | 53,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $7,115,832 | 376,300 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $19,799 | 873 | Shares | Other | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||